Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Sanofi-aventis and Kyowa Hakko Kirin enter into a Collaboration and Licensing Agreement on an Anti LIGHT fully human monoclonal antibody
Sanofi-aventis, 05/15/09
Sanofi-aventis and Kyowa Hakko Kirin Co., Ltd. announced that they have signed a collaboration and licensing agreement under which sanofi-aventis receives worldwide rights to Kyowa Hakko Kirin's anti-LIGHT fully human monoclonal antibody.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09